DBO-83 – 5 mg

Brand:
Cayman
CAS:
195211-53-1
Storage:
-20
UN-No:
Non-Hazardous - /

DBO-83 is an agonist of nicotinic acetylcholine receptors (nAChRs) with antinociceptive and anti-amnesic activities.{46007,46008,46009} It binds to nAChRs in rat cortical membranes with a Ki value of 4.1 nM in a radioligand binding assay with the α4β2 nAChR partial agonist and α7 nAChR agonist [3H]cytisine.{46007} DBO-83 dose-dependently increases the latency to paw licking in mice in the hot plate test and reduces the number of abdominal constrictions in mice in the acetic acid abdominal constriction test, effects that can be reduced by the nAChR antagonist mecamylamine (Item No. 14602).{46008} DBO-83 also dose-dependently prevents amnesia induced by mecamylamine, the muscarinic receptor antagonist scopolamine, and the nAChR antagonist dihydro-β-erythroidine in mice in the passive avoidance test.{46009}  

 

Available on backorder

SKU: 25991 - 5 mg Category:

Description

An agonist of nAChRs with antinociceptive and anti-amnesic activities; binds to nAChRs in rat cortical membranes (Ki = 4.1 nM); dose-dependently increases the latency to paw licking in mice in the hot plate test and reduces the number of abdominal constrictions in mice in the acetic acid abdominal constriction test; dose-dependently prevents amnesia induced by mecamylamine, scopolamine, and dihydro-β-erythroidine in mice in the passive avoidance test


Formal name: 3-(6-chloro-3-pyridazinyl)-3,8-diazabicyclo[3.2.1]octane, dihydrochloride

Synonyms: 

Molecular weight: 297.6

CAS: 195211-53-1

Purity: ≥98%

Formulation: A solid


Product Type|Biochemicals|Ion Channel Modulation|Activators||Research Area|Neuroscience|Behavioral Neuroscience|Learning & Memory||Research Area|Neuroscience|Pain Research